Language selection

Search

Details for: CISPLATIN INJECTION

Company: TEVA CANADA LIMITED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02403188CISPLATIN INJECTIONCISPLATIN1.0 MG / MLSOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Cisplatin - Assessing the Potential Risk of Blood Clots in the Veins (venous thromboembolism)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: